Target intelligence / Profile preview

WASP-family verprolin homologous protein 1 (WAVE1)

Target
WAVE1
Molecular classification
Actin-binding protein, Scaffolding protein, Signal transduction protein
01

Overview

WASP-family verprolin homologous protein 1 (WAVE1), encoded by the WASF1 gene, is a critical scaffolding protein involved in the regulation of the actin cytoskeleton [1][2]. It operates as part of the pentameric WAVE regulatory complex (WRC), which translocates to the plasma membrane upon activation by the small GTPase Rac1 to stimulate the Arp2/3 complex [4]. This activation leads to the formation of branched actin networks, which are essential for the generation of lamellipodia and driving cell motility [4]. In the central nervous system, WAVE1 is highly expressed and plays a vital role in neuronal morphogenesis, including the development of axons and dendritic spines, which are fundamental for synaptic plasticity and cognitive function [1][3]. Pathologically, WAVE1 is frequently upregulated in various malignancies, where it promotes tumor cell invasion and metastasis by enhancing migratory capacity [5]. Furthermore, de novo mutations in WASF1 have been identified as a cause of Sohal-Siddiqui syndrome, a neurodevelopmental disorder characterized by intellectual disability and autistic features [3]. While WAVE1 is a promising therapeutic target for inhibiting cancer metastasis and treating certain neurological conditions, there are currently no FDA-approved drugs that directly target this protein [2][5]. [1] UniProt (Q92558); [2] NCBI Gene (8936); [3] Sohal et al. (2021) PMID: 33536283; [4] Takenawa & Suetsugu (2007) PMID: 17183360; [5] Kurisu & Takenawa (2009) PMID: 19923894.

Other names
WASF1WAVESCAR1Homolog of Dictyostelium scar 1WASP family member 1Protein WAVE1
02

Mechanism of action

Acts as a downstream effector of Rac1 within the WAVE regulatory complex (WRC) to activate the Arp2/3 complex, which nucleates branched actin filament assembly at the leading edge of cells.

03

Biological functions

Actin polymerizationCell migrationLamellipodia formationNeuronal developmentSynaptic plasticityAxon guidance
04

Disease associations

CancerNeurodevelopmental disorderAlzheimer's diseaseMetastatic disease
05

Safety considerations

Potential for neurotoxicity due to roles in synaptic plasticityImpairment of physiological cell migration (e.g., wound healing)Developmental toxicityOff-target effects on the actin cytoskeleton
06

Biomarkers

WASF1 mRNA expression levelsWAVE1 protein overexpressionWRC complex stability

Beyond the preview

Go deeper on WASP-family verprolin homologous protein 1 (WAVE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WASP-family verprolin homologous protein 1 (WAVE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call